August 2, 2024
TOPLINE: Initiating medication for opioid use disorder (OUD) within 7 days of a hospital visit reduces the risk for fatal or nonfatal opioid overdose at 6 […]
August 2, 2024
TOPLINE: Emergency department (ED) visits for falls are linked to a higher short-term risk for ischemic stroke, particularly within 15 days; patients with a preceding fall […]
August 2, 2024
Image By: Christine Lee, Acting Associate Commissioner for Minority Health, Office of Minority Health and Health Equity In late June, representatives of the U.S. Food and […]
August 2, 2024
FDA has reevaluated the rationale document titled, “Daptomycin Breakpoints for Enterococci,” submitted by the Clinical and Laboratory Standards Institute (CLSI) to FDA public docket # FDA-2017-N-5925-020 […]
August 2, 2024
A new study lends weight to fears that more livestock workers have gotten the bird flu than has been reported. “I am very confident there are […]
August 2, 2024
Docket Number: FDA-2022-D-1527 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research Center for Biologics Evaluation and Research The Food and Drug Administration (FDA […]
August 2, 2024
Docket Number: FDA-2022-D-1527 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research, Office of Regulatory Policy Center for Biologics Evaluation and Research The Food […]
August 2, 2024
The US Food and Drug Administration (FDA) has expanded the approval of dostarlimab-gxly (Jemperli, GSK) in conjunction with carboplatin and paclitaxel, followed by single-agent dostarlimab-gxly, for […]
August 2, 2024
CHICAGO — Being hormone receptor positive is generally a favorable prognostic factor in breast cancer, but that doesn’t seem to be the case in women with […]